HEARTBEAM, INC. (BEAT) Announces Regulatory Update
HEARTBEAM, INC. (BEAT) provided an update on regulatory developments for its product portfolio.
Regulatory Update Details:
• Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency)
• Status: Extended Review
Clinical Development:
🔬 Clinical Development Pipeline (HEARTBEAM, INC.):
📋 HEARTBEAM, INC. (BEAT) - Regulatory Update
Filing Date: 2026-04-16
Accepted: 2026-04-16 16:48:04
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (HEARTBEAM, INC.):
💼 Business Developments:
No business developments data available.
Structured Data: